d. dobi, zs . bodó, É. kemény, k. boda a , p. szenohradszky b , e. szederkényi b , b....
DESCRIPTION
Kidney allografts with biopsy features of chronic mixed rejection reflect poorer survival than those with pure chronic antibody-mediated rejection. D. Dobi, Zs . Bodó, É. Kemény, K. Boda a , P. Szenohradszky b , E. Szederkényi b , B. Iványi - PowerPoint PPT PresentationTRANSCRIPT
Kidney allografts with biopsy features of chronic mixed rejection reflect
poorer survival than those with pure chronic antibody-mediated rejection
D. Dobi, Zs. Bodó, É. Kemény, K. Bodaa, P. Szenohradszkyb, E. Szederkényib, B. Iványi
Departments of Pathology, Medical Physics and Informaticsa and Surgeryb
University of Szeged, Szeged, Hungary
Introduction
In late dysfunctional kidney allograft biopsies
three rejection phenotypes can be observed:
• chronic antibody-mediated rejection (AMR)
• acute T-cell-mediated rejection (TMR)
• chronic active TMR
ptcmlcg
Chronic AMR: transplant glomerulopathy and/or transplant capillaropathy
Acute TMR: interstitial infiltrates and tubulitis (interstitial rejection, ISR) with or without intimal arteritis
Chronic active TMR: mononuclears in intimal fibrosis (cvmo)
• Frequency: chronic AMR > acute TMR; chronic active TMR is exceptional
• Chronic AMR and TMR may concur, termed chronic mixed rejection (CMR)
Objectives
To analyze
• the histological patterns of chronic mixed rejection (CMR)
• the clinicopathological relevance of the different patterns of CMR
Material and methods
• From 2001 to 2011, 61 biopsies displayed the histological features of chronic AMR (cg and/or ptcml ± C4d-positivity)
• Luminex data were not avaible
• Re-evaluation according to the Banff scheme (v, g, i, t, ptc, cg, ci,ct, ah) plus
• Scoring of chronic arterial changes: mononuclears in
intimal fibrosis (cvmo), intimal fibrosis (cvIF), intimal
fibroelastosis (cvIFE); and tubular HLA-DR and ptcml
• Staining of chronic active arteritis (cvmo) cases
with CD3 and CD68 in adjacent sections
• Two groups for clinicopathological analysis:
purely CAMR vs CMR
• Statistics: Spearman’s correlation, hierarchical
cluster analysis, Kaplan-Meier estimator, Cox
regression
Results: main clinical data
All
patients (n=61)
Purely CAMR (n=35)
CMR (n=26) p
Posttransplant time (months) 66±49 70±49 60±49 ns
eGFR (ml/min/1.73 m2) 26±12 28±12 23±13 ns
Postbiopsy follow-up (months) 23±22 26±22 19±20 ns
Chronic active TMR Chronic active TMR and acute ISR
Acute ISR
Purely CAMR CMR
35
12
4
10
Histological patterns
Features of chronic active arteritis
Severe luminal narrowing (median score 3),
mononuclears scattered throughout the fibrotic intima,
T-cell predominance
PAS
CD3
CD68
Significant (p<0.05) and positive Spearman correlation coefficients between Banff scores and chronic arterial changes
t HLA-DR cvmo ptc C4d g cg ptcml cvIF ci ct ah cvIFE
i 0.769 0.606 0.347 0.301 0.264t 0.654 0.2750.354
HLA-DR 0.363cvmo
ptc 0.3280.331C4d 0.303
g 0.338cg 0.258
ptcml 0.414 0.269 0.263cvIF
ci 0.806 0.299ct
ahcvIFE
Hierarchical cluster analysis
cvIF
cvIFE
cvmo
-36 -30 -24 -18 -12 -6 -1 +1 +6+12
15
20
25
30
35
40
45
50
purely CAMR
CMR
Time before (-) and after (+) biopsy (Bx) (months)
Mea
n eG
FR v
alue
(ml/m
in/1
.73
m2)
Mean eGFR values in purely CAMR and CMR
Postbiopsy therapy
Therapy
Purely CAMR CMR
CAMR (n=35)
Chronic active TMR (n=12)
Chronic active TMR and acute ISR
(n=4)
Acute ISR (n=10)
Steroid pulse 5 5 4 10
Intensification of maintenance
immunosuppression8 6 1 0
Anti-thymocyte globulin 0 0 2 0
Plasmapheresis 0 0 2 0
Left untreated 22 2 0 0
Mean graft survival in purely CAMR and CMR groups
Purely CAMR
CMR
p=0.011
50 vs 22 months
Multivariable Cox regression of morphological variables
g
ptc
ci ah
cvmo
ct
i
cg ptcml
HLA-DR
C4d
t
cvIF
cvIFECNI-tox.
Discussion
I. CMR was frequent in our series (43%)II. Chronic active arteritis appeared to be T-
cell-relateda. T-cell predominance in 14/16 casesb. Clustered with TMR lesions
C. Lefaucheur et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 2013; 381: 313-319.
III. CMR was characterized by poorer allograft survival and more reduced allograft function than purely chronic AMR if chronic active arteritis was part of the TMR component
IV. The immunohistochemical profiling of chronic active arteritis is recommended